Clinical TrialsSearch results
Number of results: 2556
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- BGB-A317-290-LTE1
- Advanced Malignancies
- IQVIA Services Japan G.K. jRCT Inquiry Contact
- 2023-06-24
Recruiting
- First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2)
- Advanced Non-Small Cell Lung Cance
- Tanigawa Takahiko
- 2022-07-31
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Recruiting
- Phase I study of MGY825 in patients with advanced non-small cell lung cancer
- advanced non-small cell lung cancer
- Yamauchi Kyosuke
- 2022-08-19
Other
- Randomized Phase III Trial Comparing Gefitinib with Carboplatin/Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- NEJ Gefitinib Study Group
- 2008-12-31
Other
- A phase II study of lenvatinib (E7080/MK-7902) in combination with carboplatin pemetrexed and pembrolizumab (MK-3475) for patients with pretreated advanced non-squamous non-small cell lung cancer harboring EGFR mutations
- Advanced non-squamous non-small cell lung cancer harboring EGFR mutations
- Takahashi Kazuhisa
- 2022-06-18
Other
- Multi-center randomized controlled trial of gemcitabine in combination with S-1 compared with gemcitabine alone in patients with advanced nonresectable pancreatic cancer
- Advanced nonresectable pancreatic cancer
- Faculty of Medicine, University of Tokyo
- 2006-10-05
Recruiting
- A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Advanced NSCLC and Other Solid Tumors
- Upadhyay Vivek
- 2024-03-12
No Longer Recruiting
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- advanced or metastatic BC, prostate cancer or other solid tumor
- Kawai Norisuke
- 2023-06-07
Other
- PF-07104091 as a Single Agent and in Combination Therapy
- Advanced or metastatic breast cancer and other solid tumor
- Kawai Norisuke
- 2022-06-14